About us | About Scoope | Contact us
Scopelogo
 
google

 
  
 Sponsor Links
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEWS ARCHIVE  
  News archives across months
  News archives across themes
  News archives across category
   
 
   
 

Reed appoints Shan Mei as chairman in China - 13 Dec 2005

Publisher Reed Elsevier, Netherlands, has announced the appointment of Shan Mei as chairman of the company's Chinese operations. He will report to Reed's chief strategy officer, Nick Baker. This move is being looked upon as the company's strategy to expand its business in China.

In his new appointment, Mei will be expected to expand Reed's existing joint ventures in China and also increase its publications in the local language.

Mei was with former US Secretary of State, Henry Kissinger, for the past 20 years. He will be expected to use his influence with the Beijing government to ease Reed's way in the publishing and information sector.

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

Nature archives go back to 1960 - 13 Dec 2005

Nature Publishing Group (NPG), UK, has announced the addition of another decade of Nature issues to its online archive at www.nature.com/nature/archive. This includes 53,069 articles from 522 issues published between January 1960 and December 1969. Nature is presently digitising archives back to 1950. The content is being released in instalments of 10 years until its completion in late 2006. Once completed, the Nature archive will contain nearly 154,500 articles from 2,399 issues.

The Nature archives now provide primary editorial information through the web. They provide access to all editorial content including news and comments, articles and letters, news and views, review material, literature and essays and supplements from the print issues. All images available within online copyright have also been included.

NPG has put in a number of online functionalities expected from a web resource for researchers . Each article contains the PDF version of the full article, an HTML abstract, and hyperlinked references using the abstracting services of CrossRef, Medline and ISI including the ISI Web of Science.

As a part of the NPG online medium, the Nature archive has significant searching ability and integration with existing content from the NPG portfolio.

Nature is available to institutions through a site licence that provides access to all issues from January 1997 to the current issue. Nature archive, January 1987 - December 1996 and January 1950 - December 1986 can be accessed with signed addendums. The final instalment of the Nature archive, January 1950 - December 1986, will include all content published between 1950 and 1959, and is due for release in 2006.

To read original press release click here

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

'Blood' reports on positive responses to experimental leukaemia drug - 13 Dec 2005

Gene-based pharmaceutical firm ChemGenex Pharmaceuticals Ltd., Australia, has announced that two abstracts related to the clinical development of its experimental leukaemia drug, Ceflatonin, have been published in Volume 106, Issue 11 of Blood.

The journal is the official publication of the American Society of Hematology (ASH). The abstracts, prepared by researchers from the University of Texas M.D. Anderson Cancer Center, can be accessed on the ASH web site at http://www.hematology.org.

The studies have been found to support the development plan for Ceflatonin (homoharringtonine, or HHT). In the first study, HHT was delivered subcutaneously to late chronic stage chronic myeloid leukemia patients with resistance to Gleevec, a Novartis drug. All five evaluable patients were found to respond well. In the second study, nine myelodysplastic syndrome patients showed positive response to HHT after the first cycle of treatment. These results are seen as backing a shift to subcutaneous delivery. Also, the drug is expected to address a wide range of diseases.

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

Peer review gets an upper hand over open access - 13 Dec 2005

In a recent study conducted by the Centre for Information Behaviour and the Evaluation of Research (CIBER), based at University College, London, 96.2 percent of academics have voted for the method of peer review for publication of scholarly articles. The study based on the responses from 5,513 academics was jointly sponsored by The Publishers Association and the International Association of STM Publishers.

Even though peer review received great support, many respondents disapproved of the cost of journals and the extent of time taken between submission and publication.

While 41 percent voted for open access (OA) publishing, almost half opined that it would weaken the current system. Though 30 percent of authors claimed to know 'a lot' or 'quite a lot' about OA, according to the survey authors, there is a lot of confusion about OA.

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

Swiss scientist appointed Editor-in-Chief of 'HIV Clinical Trials' - 13 Dec 2005

Thomas Land Publishers, Inc., US, has announced the appointment of physician and researcher Dr. Milos Opravil as Editor-in-Chief of its journal, HIV Clinical Trials (HCT), from January 2006. He will succeed Dr. Maurice Staquet, HCT's founding Editor-in-Chief for the past six years, who will continue to serve on the editorial board.

Dr. Opravil serves as a professor of Infectious Diseases and Internal Medicine at the University of Zurich, Switzerland. He has also been a member of the Scientific Board of the Swiss HIV Cohort Study since 1995. Apart from this, he is a visiting physician at the University Hospital of Zurich.

Since its launch in July 2000, HIV Clinical Trials, an independent, peer-reviewed and international journal, has published research articles of over 1,000 leading scientists in HIV therapeutics. Thomas Land specialises in bringing out rehabilitation and clinical medicine publications.

To read original press release click here.

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

US haematology association announces awards - 13 Dec 2005

The American Society of Hematology (ASH) has announced that it will honour Sen. Arlen Specter and Dr. Daniel Rosenblum for their dedicated service in the field of haematology during its 47th Annual Meeting. ASH, a professional society of blood specialists and publisher of the journal Blood, promotes clinical care, training, research, education and advocacy in haematology.

Sen. Specter will be honoured with the ASH Public Service Award, which is presented to a public official actively involved in issues of importance to haematology. He is being recognised for his legislative initiatives, commitment and efforts to support biomedical research. He has also worked with ASH and other non-profit publishers to address concerns on how the new NIH policy on scientific publishing will impact society journals.

Dr. Rosenblum will be honoured with the Outstanding Service Award, which is presented to an individual who has demonstrated efficient leadership from 'behind-the-scenes' in areas related to the mission of the Society.

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

Corrigendum - 13 Dec 2005

This is with reference to the news alert on Thomson Scientific titled "Thomson Scientific unveils bibliographic tool, EndNote Web" covered in the News Section of Knowledgespeak (dated 02nd Dec 2005). The line 'Thomson Scientific, US, part of Thomson Corporation, in association with Thomson ResearchSoft has announced the launch of EndNote Web' should instead read as 'Thomson Scientific and Thomson ResearchSoft announced the development of EndNote Web(TM)'. The error is deeply regretted.

Forward ThisForward This
 

 
STORY TOOLS
Bookmark and Share
Share On LinkedInShare
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections
 
For banner ads click here